Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Jun 18, 2021; 11(6): 147-160
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.147
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.147
Managing cardiovascular disease risk in South Asian kidney transplant recipients
G V Ramesh Prasad, Vaishnavi Bhamidi, Kidney Transplant Program, St. Michael's Hospital, Toronto M5C 2T2, ON, Canada
Author contributions: Prasad GVR designed the study, critically reviewed and appraised the literature and wrote the paper; Bhamidi V critically reviewed and appraised the literature; Both authors read and approved the final manuscript.
Conflict-of-interest statement: The authors do not have any conflicts of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: G V Ramesh Prasad, MBBS, PhD, Professor, Kidney Transplant Program, St. Michael's Hospital, 61 Queen Street East, 9th Floor, Toronto M5C 2T2, ON, Canada. ramesh.prasad@unityhealth.to
Received: February 26, 2021
Peer-review started: February 26, 2021
First decision: March 31, 2021
Revised: April 12, 2021
Accepted: May 22, 2021
Article in press: May 22, 2021
Published online: June 18, 2021
Processing time: 106 Days and 1.1 Hours
Peer-review started: February 26, 2021
First decision: March 31, 2021
Revised: April 12, 2021
Accepted: May 22, 2021
Article in press: May 22, 2021
Published online: June 18, 2021
Processing time: 106 Days and 1.1 Hours
Core Tip
Core Tip: South Asian kidney transplant recipients are at higher risk for cardiovascular disease. Aggressive management should begin before transplantation and continue into the post-transplant phase. Each risk factor should be managed individually to reduce cardiovascular risk and improve post-transplant outcomes.